NCT02626182View on ClinicalTrials.gov

Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 18, 2018

Study Completion Date

January 29, 2018

Conditions
Cystic Fibrosis
Interventions
DRUG

sildenafil

active sildenafil

DRUG

placebo

sugar pill that looks like sildenafil tablets

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors
lead

National Jewish Health

OTHER

NCT02626182 - Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF | Biotech Hunter | Biotech Hunter